4//SEC Filing
Lydon Nicholas 4
Accession 0001415889-22-005656
CIK 0001597264other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:05 PM ET
Size
6.7 KB
Accession
0001415889-22-005656
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-05-23−10,909→ 0 totalExercise: $19.53Exp: 2026-06-23→ Common Stock (10,909 underlying) - Exercise/Conversion
Common Stock
2022-05-23$19.53/sh+10,909$213,053→ 50,584 total
Footnotes (1)
- [F1]This option was granted on June 23, 2016 and is fully vested.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001639935
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:05 PM ET
- Size
- 6.7 KB